Scaling Canadian Life Science Innovation Capacity — from Entrepreneurs to Infrastructure Home Resources Scaling Canadian Life Science Innovation Capacity — from Entrepreneurs to Infrastructure Home Posted March 16, 2022 Canada’s fertile life science innovation ecosystem and its ability to produce enabling technologies represents an opportunity to develop world-leading medical technologies and therapeutic companies. However, to fully capitalize on the value creation potential of this foundation, entrepreneurial, financial and infrastructure resources must be scaled.Ali Tehrani, Michael Mee, and Virginie Petel Legare of Amplitude Ventures discuss with CVCA’s CEO, Kim Furlong, the fund’s vision for its platform to create and accelerate the growth of companies. We will touch on innovative programs the team is advancing like the Amplitude Fellowship program, a first of its kind in the country, to educate and inspire the next generation of entrepreneurs.Panelists:Ali Tehrani, Venture Partner, Amplitude VenturesMichael Mee, Principal, Amplitude VenturesVirginie Petel Legare, 2021 Amplitude Fellow, Ph.D. Candidate McGill UniversityModerator: Kim Furlong, CEO, CVCA